tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Cardiol Therapeutics: Promising Developments in Cardiac Disease Treatment with CardiolRx
RatingsCardiol Therapeutics: Promising Developments in Cardiac Disease Treatment with CardiolRx
14d ago
CRDL
Cardiol Therapeutics Reports Q2 2025 Financial Results Amid Rising Losses
PremiumCompany Announcements
Cardiol Therapeutics Reports Q2 2025 Financial Results Amid Rising Losses
15d ago
6K
CRDL
Cardiol Therapeutics to Present at Canaccord Genuity Conference
PremiumCompany Announcements
Cardiol Therapeutics to Present at Canaccord Genuity Conference
18d ago
CRDL
Roth bullish on Cardiol, says trial results enough to attract larger partner
PremiumThe Fly
Roth bullish on Cardiol, says trial results enough to attract larger partner
23d ago
CRDL
Optimistic Buy Rating for Cardiol Therapeutics Amid Promising Clinical Trial Results and Strategic Advancements
PremiumRatings
Optimistic Buy Rating for Cardiol Therapeutics Amid Promising Clinical Trial Results and Strategic Advancements
23d ago
CRDL
Cardiol ARCHER study not statistically significant, says Canaccord
PremiumThe FlyCardiol ARCHER study not statistically significant, says Canaccord
23d ago
CRDL
Cardiol falls 14% to $1.16 after myocarditis study results
Premium
The Fly
Cardiol falls 14% to $1.16 after myocarditis study results
23d ago
CRDL
Cardiol data readout positive and not priced in, says H.C. Wainwright
Premium
The Fly
Cardiol data readout positive and not priced in, says H.C. Wainwright
23d ago
CRDL
Cardiol Therapeutics announces Phase II ARCHER results in myocarditis
PremiumThe Fly
Cardiol Therapeutics announces Phase II ARCHER results in myocarditis
23d ago
CRDL
Cardiol Therapeutics Reports Promising Phase II Trial Results for CardiolRx™ in Acute Myocarditis
PremiumCompany Announcements
Cardiol Therapeutics Reports Promising Phase II Trial Results for CardiolRx™ in Acute Myocarditis
23d ago
CRDL
Positive Outlook for Cardiol Therapeutics Amid ARCHER Trial Progress and Market Potential
PremiumRatings
Positive Outlook for Cardiol Therapeutics Amid ARCHER Trial Progress and Market Potential
1M ago
CRDL
Cardiol Therapeutics Achieves Database Lock in ARCHER Trial for Acute Myocarditis
PremiumCompany Announcements
Cardiol Therapeutics Achieves Database Lock in ARCHER Trial for Acute Myocarditis
1M ago
6K
CRDL
Buy Rating for Cardiol Therapeutics: Promising Innovations in Heart Disease Treatment with CardiolRx and CRD-38
PremiumRatingsBuy Rating for Cardiol Therapeutics: Promising Innovations in Heart Disease Treatment with CardiolRx and CRD-38
3M ago
CRDL
Cardiol Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Cardiol Therapeutics initiated with a Buy at H.C. Wainwright
3M ago
CRDL
Cardiol Therapeutics Announces AGM Results and New Board Member
Premium
Company Announcements
Cardiol Therapeutics Announces AGM Results and New Board Member
3M ago
6K
CRDL
Cardiol Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Cardiol Therapeutics Reports Q1 2025 Financial Results
3M ago
CRDL
Cardiol Therapeutics to Webcast AGM Amidst Ongoing Clinical Trials
PremiumCompany Announcements
Cardiol Therapeutics to Webcast AGM Amidst Ongoing Clinical Trials
3M ago
6K
CRDL
Promising Clinical Developments and Investment Potential in Cardiol Therapeutics
PremiumRatings
Promising Clinical Developments and Investment Potential in Cardiol Therapeutics
4M ago
CRDL
Cardiol Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Cardiol Therapeutics Reports Q1 2025 Financial Results
4M ago
6K
CRDL
Promising Prospects for Cardiol Therapeutics: Buy Rating Backed by Strong Market Potential and Innovative Treatment Developments
PremiumRatingsPromising Prospects for Cardiol Therapeutics: Buy Rating Backed by Strong Market Potential and Innovative Treatment Developments
4M ago
CRDL
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Board Amid Phase III Trial Progress
Premium
Company Announcements
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Board Amid Phase III Trial Progress
4M ago
6K
CRDL
Cardiol Therapeutics Schedules Virtual Annual General Meeting for May 2025
Premium
Company Announcements
Cardiol Therapeutics Schedules Virtual Annual General Meeting for May 2025
4M ago
6K
CRDL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >